H.Z. Ke

FDA guidelines and animal models for osteoporosis

David D. Thompson, Hollis A. Simmons, C.M. Pirie et al. · Bone · 1995 · 525 citations

Medicine, Animal Sciences, Endocrinology +14

An EP2 receptor-selective prostaglandin E ₂ agonist induces bone healing

Vishwas Paralkar, Fran Borovečki, H.Z. Ke et al. · Proceedings of the National Academy of Sciences · 2003 · 186 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.

H.Z. Ke, Hollis A. Simmons, C.M. Pirie et al. · Endocrinology · 1995 · 114 citations

Medicine, Endocrinology, Pharmacology +15

Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.

Gary N. Mann, Thomas Jacobs, Farrel J. Buchinsky et al. · Endocrinology · 1994 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +17

Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization.

H.Z. Ke, Dale Mayrose, Wen Cao · Proceedings of the National Academy of Sciences · 1993 · 82 citations

Life Sciences, Biochemistry, Pharmacology +17